An article published in Nature suggested that shRNA-mediated inhibition of PCGEM1 strongly suppressed tumor growth in a CWR22Rv1-induced PC xenograft mouse model, indicating a significant regulatory effect of PCGEM1 on the growth of castration-resistant prostate cancer (CRPC) (26). Here, PCGEM1 is linked to neoplasm.